Literature DB >> 1695413

Cell proliferation during the process of bleomycin-induced pulmonary fibrosis in rats.

M Kawamoto1, Y Fukuda.   

Abstract

To elucidate the relationship between cell proliferation and structural remodeling in pulmonary fibrosis, light and electron microscopy with immunohistochemistry for bromodeoxyuridine (BrdU) and morphometry for BrdU-positive cells were performed following a single intratracheal instillation of bleomycin in rats. The results showed that terminal bronchiolar epithelial cells, Type II alveolar epithelial cells and interstitial cells began to proliferate 2 days after the injury. Then each cell type showed a different style of proliferation. Interstitial cells which were located in the interstitium and migrated into intraalveolar spaces proliferated, then produced intra-alveolar fibrosis. Terminal bronchiolar epithelial cells proliferated rapidly and formed alveolar bronchiolization with squamous metaplasia in areas where alveoli were severely damaged and intraalveolar fibrosis was formed, and thereafter the proliferation ceased within 2 weeks. The degree of proliferation of type II alveolar epithelial cells and interstitial cells was rather slight, but continued constantly until the later stage. In addition, intraalveolar macrophages were BrdU-positive from an early stage. Endothelial cell proliferation was observed in small vessels and alveolar capillaries at 1 week after bleomycin instillation. Rapidly proliferating bronchiolar epithelial cells which formed alveolar bronchiolization with squamous metaplasia were important in preventing the progress of intraalveolar fibrosis, because the proliferation of type II alveolar epithelial cells was limited.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695413     DOI: 10.1111/j.1440-1827.1990.tb01556.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  10 in total

1.  Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin.

Authors:  T Betsuyaku; Y Fukuda; W C Parks; J M Shipley; R M Senior
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Radiation-induced changes in breathing frequency and lung histology of C57BL/6J mice are time- and dose-dependent.

Authors:  T Eldh; F Heinzelmann; A Velalakan; W Budach; C Belka; V Jendrossek
Journal:  Strahlenther Onkol       Date:  2012-03       Impact factor: 3.621

Review 3.  Stem cells and regenerative medicine in lung biology and diseases.

Authors:  Allison N Lau; Meagan Goodwin; Carla F Kim; Daniel J Weiss
Journal:  Mol Ther       Date:  2012-03-06       Impact factor: 11.454

4.  Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition.

Authors:  Jason R Rock; Christina E Barkauskas; Michael J Cronce; Yan Xue; Jeffrey R Harris; Jiurong Liang; Paul W Noble; Brigid L M Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

Review 5.  Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.

Authors:  Vanessa J Craig; Li Zhang; James S Hagood; Caroline A Owen
Journal:  Am J Respir Cell Mol Biol       Date:  2015-11       Impact factor: 6.914

6.  Intraluminal fibrosis and elastic fiber degradation lead to lung remodeling in pulmonary Langerhans cell granulomatosis (histiocytosis X).

Authors:  Y Fukuda; F Basset; P Soler; V J Ferrans; Y Masugi; R G Crystal
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

Review 7.  Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play.

Authors:  Lourdes Chuliá-Peris; Cristina Carreres-Rey; Marta Gabasa; Jordi Alcaraz; Julián Carretero; Javier Pereda
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

8.  Lung lymphocytes proliferate minimally in the murine pulmonary immune response to intratracheal sheep erythrocytes.

Authors:  G D Seitzman; J Sonstein; S Kim; W Choy; J L Curtis
Journal:  Am J Respir Cell Mol Biol       Date:  1998-06       Impact factor: 6.914

9.  Attenuation of acute nitrogen mustard-induced lung injury, inflammation and fibrogenesis by a nitric oxide synthase inhibitor.

Authors:  Rama Malaviya; Alessandro Venosa; Leroy Hall; Andrew J Gow; Patrick J Sinko; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2012-09-06       Impact factor: 4.219

10.  Early and late changes of MMP-2 and MMP-9 in bleomycin-induced pulmonary fibrosis.

Authors:  Ji Young Kim; Hyun Cheol Choeng; Cheolmin Ahn; Sang-Ho Cho
Journal:  Yonsei Med J       Date:  2009-02-24       Impact factor: 2.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.